Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15007 total
BioCryst Pharmaceuticals is trading with a striking divergence this week: short interest remains historically elevated at 15.3% of the float, yet options traders are the most bullish they have been all year. The…
Axcelis Technologies heads into late August with two signals quietly moving in the same direction — short sellers are adding exposure and options traders are leaning more defensive than they have been in weeks. The…
Associated Banc-Corp enters the final week of August with an unusual split: a cluster of insider selling at the executive level sits alongside the most call-heavy options positioning the stock has seen all year. The…
AAPL heads into the final days of August with short sellers at their most relaxed in months — yet the stock's real narrative has little to do with positioning and everything to do with what happens on September 1. The…
American Express heads into the final week of August with analysts broadly constructive yet quietly trimming targets after last month's earnings — a mild tension for a stock that still trades roughly 11% below…
AMZN has quietly clawed back to $261 — up 0.6% on the week and 12.5% over the past month — yet the gap between where the stock trades and where analysts think it should be remains stubbornly wide. The Street's…
AMD recovered 4.9% on Tuesday to close at $479.18 — a sharp single-session rebound, but one that barely dents the damage accumulated over the past month. The bounce follows a brutal stretch. AMD is down 8% over the…
Abercrombie & Fitch has just cleared its August 26 earnings hurdle, but the session after the print has raised a fresh tension: short sellers added positions sharply on the day, the COO's selling cadence remains…
ABT has added another layer to its already constructive setup: a fresh target raise from a bellwether name, a stock now up 12% over the past month, and short sellers continuing to exit a name that has given them little…
GRPN has slipped another 3% on the week to $19.59 — and for the first time in months, short sellers are actually pulling back rather than pressing, though the borrow market remains far too tight to call this a genuine…
DKS delivered its August 25 earnings report — and the pre-print call-buying that looked decisive last week turned out to be badly timed, with the stock collapsing 31% on the day to $124.31. The options pivot described…
INTU delivered its fiscal Q4 numbers on August 20 and rallied hard — but the Street's response on August 26 tells a more complicated story, with a wave of target reductions arriving just as the stock hit its highest…
ASST has now added 67% in a single week and 86% over the past month, yet the lending market is quietly tightening again — a dynamic that sits uncomfortably alongside a short score still running well above average. The…
C.H. Robinson Worldwide presents a striking contradiction this week: the stock has collapsed 23% over the past month to $143.66, yet short sellers are rushing for the exit, not the entrance. Short interest has fallen…
CRE is a stock where the most striking tension is not in the lending market — it's in the gap between where the shares trade and where analysts think they should be. The valuation setup is the standout angle here.…
WEN has extended its August recovery to $9.01 — up 18% over the past month — yet the structural short position remains enormous and the options market has now spent a full week at its most bullish extreme, a…
AST SpaceMobile ends the week in a state of productive tension — short sellers have now trimmed over 12 million shares from their peak position, yet the borrow market has barely thawed, leaving a 20% short float on a…
Iovance Biotherapeutics gave back 7.8% on Friday to close at $8.29, yet still logged an 18.8% gain on the week — and the most notable shift in the data this week is not in the short book but in options, where defensive…
JS Global Lifestyle (1691) heads into its August 28 interim results with the most hostile borrow market in its recent history — and the stock has just staged a sharp rally that is making that borrow even more expensive…
Rabigh Refining and Petrochemical Company enters the final week of August having gained nearly 5% on the week and almost 20% over the past month — yet the borrow market has tightened meaningfully alongside the rally,…
